Providence Little Company of Mary Recovery Center
-
Services:
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Detoxification
- Federal military insurance (e.g., TRICARE)
- Private health insurance
- Cash or self-payment
- Federal, or any government funding for substance use treatment programs
- Medicare
- Suicide prevention services
- Domestic violence services, including family or partner
- Early intervention for HIV
- Transportation assistance
- Mental health services
- Case management service
- Social skills development
- Young Adults
- Adults
- Lofexidine or Clonidine detoxification
- Prescribes naltrexone
- Relapse prevention with naltrexone
- Buprenorphine detoxification
- Buprenorphine maintenance
- Prescribes buprenorphine
- Accepts clients using MAT but prescribed elsewhere
- Vaping permitted in designated area
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Self-help groups
- Recovery coach
- Mentoring/peer support
- Assistance with obtaining social services
- Housing services
- Members of military families
- Clients who have experienced sexual abuse
- Active duty military
- Criminal justice (other than DUI/DWI)/Forensic clients
- Clients with co-occurring pain and substance use disorders
- Clients with HIV or AIDS
- Clients with co-occurring mental and substance use disorders
- Veterans
- Adult women
- Seniors or older adults
- Clients who have experienced intimate partner violence, domestic violence
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Clients who have experienced trauma
- Adult men
- Private non-profit organization
- Opioids detoxification
- Alcohol Detoxification
- Benzodiazepines Detoxification
- Medication routinely used during detoxification
- Cocaine Detoxification
- Methamphetamines detoxification
- Comprehensive substance use assessment
- Screening for tobacco use
- Screening for mental disorders
- Outreach to persons in the community
- Complete medical history/physical exam
- Comprehensive mental health assessment
- Screening for substance use
- Hospital inpatient/24-hour hospital inpatient
- Outpatient
- Hospital inpatient detoxification
- Hospital inpatient treatment
- Intensive outpatient treatment
- Smoking permitted in designated area
- Hepatitis A (HAV) vaccination
- Hepatitis B (HBV) vaccination
- Hospital licensing authority
- The Joint Commission
- State department of health
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Outcome follow-up after discharge
- Discharge Planning
- Aftercare/continuing care
- Naloxone and overdose education
- No formal relationship with prescribing entity
- In-network prescribing entity
- Naltrexone (extended-release, injectable)
- Medication for mental disorders
- Medications for HIV treatment
- Lofexidine
- Buprenorphine without naloxone
- Disulfiram
- Buprenorphine with naloxone
- Clonidine
- Nicotine replacement
- Buprenorphine (extended-release, injectable)
- Acamprosate (CampralĀ®)
- Non-nicotine smoking/tobacco cessation
- Medications for Hepatitis C treatment
- Naltrexone (oral)
- Treatment for other addiction disorder
- Treatment for gambling disorder
- HIV or AIDS education, counseling, or support
- Group counseling
- Family counseling
- Substance use disorder education
- Individual counseling
- Smoking/vaping/tobacco cessation counseling
- Hepatitis education, counseling, or support
- Health education services other than HIV/AIDS or hepatitis
- Sign language services for the deaf and hard of hearing
- 12-step facilitation
- Community reinforcement plus vouchers
- Motivational interviewing
- Anger management
- Brief intervention
- Substance use disorder counseling
- Contingency management/motivational incentives
- Relapse prevention
- Cognitive behavioral therapy
- Trauma-related counseling
- Matrix Model
- Male
- Female
- STD testing
- Drug and alcohol oral fluid testing
- Metabolic syndrome monitoring
- Breathalyzer or blood alcohol testing
- Testing for Hepatitis B (HBV)
- TB screening
- Drug or alcohol urine screening
- Testing for Hepatitis C (HCV)
- HIV testing
- In-network prescribing entity
- No formal relationship with prescribing entity
Type of Care
Payment/Insurance/Funding Accepted
Ancillary Services
Age Groups Accepted
Type of Opioid Treatment
Facility Vaping Policy
Type of Alcohol Use Disorder Treatment
Recovery Support Services
Special Programs/Groups Offered
Facility Operation (e.g., Private, Public)
Detoxification (medical withdrawal) Services
Assessment/Pre-treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Facility Smoking Policy
Medical Services
License/Certification/Accreditation
Opioid Medications used in Treatment
Transitional Services
External Source of Medications Used for Alcohol Use Disorder Treatment
Pharmacotherapies
Other Services
Education and Counseling Services
Language Services
Treatment Approaches
Gender Accepted
Testing
External Opioid Medications Source